Home LiteratureArticle Details
PMID: 6364429 Published · ppublish English Journal Article Review

Complement, viruses, and virus-infected cells.

Springer seminars in immunopathology ·Vol. 6 ·No. 4 ·1983-00-00 ·Pages 327-47

Cooper NR, Nemerow GR

Abstract

暂无摘要

MeSH Terms
Antibodies, Viral/immunology Complement Activation Complement System Proteins/physiology Humans Virus Diseases/immunology Viruses/immunology
Chemicals
Antibodies, Viral Complement System Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Cooper N R
Nemerow G R
References (62)
62 references, click to expand
  1. Alterations in expression of measles virus polypeptides by antibody: molecular events in antibody-induced antigenic modulation.
    J Immunol. 1980 Jul;125(1):78-85 PMID: 7381212
  2. The formation and fate of virus antigen-antibody complexes.
    J Immunol. 1977 Jan;118(1):316-22 PMID: 830754
  3. Antibody-independent neutralization of vesicular stomatitis virus by human complement. II. Formation of VSV-lipoprotein complexes in human serum and complement-dependent viral lysis.
    J Immunol. 1979 Dec;123(6):2518-24 PMID: 227957
  4. Immune virolysis: effect of antibody and complement on C-type RNA virus.
    Science. 1970 Jun 19;168(3938):1478-80 PMID: 4315656
  5. Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.
    J Immunol. 1983 Mar;130(3):1317-22 PMID: 6822737
  6. Inactivation of lysis of oncornaviruses by human serum.
    Virology. 1976 Oct 15;74(2):432-40 PMID: 62448
  7. Antibody-independent neutralization of vesicular stomatitis virus by human complement. I. Complement requirements.
    J Immunol. 1978 Oct;121(4):1549-57 PMID: 212482
  8. Antibody-induced redistribution of measles virus antigens on the cell surface.
    J Immunol. 1974 Oct;113(4):1205-9 PMID: 4606230
  9. Antibody-induced capping of measles virus antigens on plasma membrane studied by electron microscopy.
    J Virol. 1975 May;15(5):1248-55 PMID: 49437
  10. Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum.
    J Immunol. 1981 Apr;126(4):1562-8 PMID: 6259260
  11. Raji cell injury and subsequent lysis by the purified cytolytic alternative pathway of human complement.
    Clin Immunol Immunopathol. 1980 Mar;15(3):384-96 PMID: 6899978
  12. Herpesvirus neutralization: the role of complement.
    J Immunol. 1971 Nov;107(5):1235-42 PMID: 5000723
  13. Activation of the alternative complement pathway by enveloped viruses containing limited amounts of sialic acid.
    Virology. 1981 Oct 30;114(2):507-15 PMID: 6270885
  14. Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells.
    Eur J Immunol. 1978 Jul;8(7):453-8 PMID: 211040
  15. Isolation of Epstein Barr-virus and studies of its neutralization by human IgG and complement.
    J Immunol. 1981 Jul;127(1):272-8 PMID: 6263973
  16. Neutralization of sensitized virus by purified components of complement.
    Proc Natl Acad Sci U S A. 1970 Mar;65(3):528-35 PMID: 4315612
  17. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.
    Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415-9 PMID: 6261256
  18. Human serum lyses RNA tumour viruses.
    Nature. 1975 Oct 16;257(5527):612-4 PMID: 170540
  19. The morphological and biological effects of various antisera on avian infectious bronchitis virus.
    J Gen Virol. 1968 Jul;3(1):97-102 PMID: 5692879
  20. Antibody-complement interactions with purified lymphocytic choriomeningitis virus.
    Virology. 1976 Aug;73(1):59-71 PMID: 986722
  21. Alternative complement pathway-mediated lysis of measles virus infected cells: induction by IgG antibody bound to individual viral glycoproteins and comparative efficacy of F(ab')2 and Fab' fragments.
    J Immunol. 1979 Nov;123(5):2144-9 PMID: 489977
  22. Mechanisms of activation of human natural killer cells against tumor and virus-infected cells.
    Immunol Rev. 1979;44:125-163 PMID: 153888
  23. THE STRUCTURE OF ANTIGEN-ANTIBODY COMPLEXES. A STUDY BY ELECTRON MICROSCOPY.
    J Exp Med. 1963 Sep 1;118:327-40 PMID: 14077994
  24. Neutralization of sensitized virus by the fourth component of complement.
    Science. 1969 Aug 1;165(3892):508-9 PMID: 4183180
  25. Lysis of measles virus-infected cells by the purified cytolytic alternative complement pathway and antibody.
    J Exp Med. 1979 Sep 19;150(3):445-54 PMID: 479760
  26. Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway.
    J Exp Med. 1976 Oct 1;144(4):970-84 PMID: 62019
  27. Formation and biologic role of polyoma virus-antibody complexes. A critical role for complement.
    J Exp Med. 1974 Aug 1;140(2):549-65 PMID: 4367757
  28. Lysis of human cultured lymphoblastoid cells by cell-induced activation of the properdin pathway.
    Science. 1977 Mar 4;195(4281):878-80 PMID: 402691
  29. Immunologic injury of cultured cells infected with measles virus. I. role of IfG antibody and the alternative complement pathway.
    J Exp Med. 1975 Apr 1;141(4):761-74 PMID: 1092789
  30. Immunologic injury in measles virus infection. II. Suppression of immune injury through antigenic modulation.
    J Exp Med. 1975 Oct 1;142(4):864-76 PMID: 1176889
  31. Immunologic injury in measles virus infection. IV. Antigens modulation and abrogation oflymphocyte lysis of virus-infected cells.
    Clin Immunol Immunopathol. 1978 Jan;9(1):55-62 PMID: 618410
  32. Immunological destruction of herpes simplex virus I infected cells.
    Nature. 1974 Oct 11;251(5475):542-3 PMID: 4371311
  33. The role of immunoglobulins in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway.
    J Immunol. 1981 Jan;126(1):11-5 PMID: 6905857
  34. The role of complement in viral infections. III. Activation of the classical and alternative complement pathways by Sindbis virus.
    J Immunol. 1980 May;124(5):2507-10 PMID: 7365263
  35. Analysis of complement-dependent antibody-mediated lysis of target cells acutely infected with measles.
    J Immunol. 1976 Jul;117(1):208-15 PMID: 819582
  36. Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera.
    J Immunol. 1977 Jan;118(1):28-34 PMID: 187701
  37. Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.
    Proc Natl Acad Sci U S A. 1978 May;75(5):2416-20 PMID: 276881
  38. Complement and cell membranes.
    Transplant Rev. 1976;32:72-92 PMID: 824770
  39. IgG on mouse erythrocytes augments activation of the human alternative complement pathway by enhancing deposition of C3b.
    J Immunol. 1981 May;126(5):1805-9 PMID: 6908606
  40. Assembly of the cytolytic alternative pathway of complement from 11 isolated plasma proteins.
    J Exp Med. 1978 Dec 1;148(6):1722-7 PMID: 722244
  41. Immune lysis of Sindbis virus.
    Virology. 1975 Aug;66(2):620-4 PMID: 808033
  42. Antibody-mediated destruction of virus-infected cells.
    Adv Immunol. 1980;29:209-60 PMID: 6251708
  43. The morphology of virus-antibody interaction.
    Adv Virus Res. 1969;15:307-38 PMID: 4106790
  44. Complement components required for virus neutralization by early immunoglobulin antibody.
    Proc Natl Acad Sci U S A. 1969 Oct;64(2):520-7 PMID: 4982356
  45. Complement-mediated lysis of African swine fever virus-infected cells.
    Immunology. 1982 May;46(1):75-82 PMID: 7076281
  46. Oncornavirus lytic activity in the serum of gibbon apes.
    J Natl Cancer Inst. 1978 Mar;60(3):677-82 PMID: 203712
  47. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.
    Adv Immunol. 1979;27:51-177 PMID: 92183
  48. Complement-mediated lysis of type-C virus: effect of primate and human sera on various retroviruses.
    Int J Cancer. 1978 Jan 15;21(1):6-11 PMID: 75191
  49. Virus neutralization and virus-induced immune complex disease. Virus-antibody union resulting in immunoprotection or immunologic injury--two sides of the same coin.
    Prog Med Virol. 1975;19:84-119 PMID: 164055
  50. Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathway.
    J Exp Med. 1976 May 1;143(5):1027-41 PMID: 177712
  51. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
    J Exp Med. 1976 Oct 1;144(4):1076-93 PMID: 978134
  52. Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.
    J Clin Invest. 1982 Nov;70(5):1081-91 PMID: 6290536
  53. The mechanisms of neutralization of sensitized equine arteritis virus by complement components.
    J Gen Virol. 1974 Nov;25(2):229-37 PMID: 4474357
  54. Rate-zonal centrifugation of herpes simplex virus-antibody complexes.
    Virology. 1971 Jan;43(1):321-5 PMID: 5313163
  55. Complement activation by measles virus cytotoxic antibodies: alternative pathway C activation by hemagglutination-inhibition antibodies but classical activation by hemolysin antibodies.
    J Immunol. 1977 Feb;118(2):533-9 PMID: 402419
  56. Enhancement of haemolysis by Newcastle disease virus (NDV) after pre-treatment with heterophile antibody and complement.
    J Gen Virol. 1976 Dec;33(3):459-69 PMID: 1036749
  57. Host cell modification of lymphocytic choriomeningitis virus and Newcastle disease virus altering viral inactivation by human complement.
    J Immunol. 1977 Jan;118(1):348-54 PMID: 830758
  58. Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins.
    J Exp Med. 1977 Jul 1;146(1):22-33 PMID: 559720
  59. Antibody-independent activation of the alternative complement pathway by measles virus-infected cells.
    Proc Natl Acad Sci U S A. 1980 Jan;77(1):559-62 PMID: 6928644
  60. Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins.
    J Exp Med. 1979 Apr 1;149(4):870-82 PMID: 372483
  61. Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E.
    J Exp Med. 1978 Mar 1;147(3):844-53 PMID: 632750
  62. Mouse natural killer cells: induction specificity, and function.
    J Immunol. 1978 Nov;121(5):1631-5 PMID: 361888
Article Info
Journal
Springer seminars in immunopathology
Abbr.
Springer Semin Immunopathol
ISSN
0344-4325
DOI
10.1007/BF02116278
Published
1983-00-00
Pages
327-47
Language
English
Region
Germany
NLM ID
7910384
PMCID
PMC7087538
Subset
IM
External Links
PubMed source DOI: 10.1007/BF02116278 PMC Full Text
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2